Your browser doesn't support javascript.
loading
Effectiveness of Pregabalin for Treatment of Burning Mouth Syndrome
Clinical Psychopharmacology and Neuroscience ; : 139-142, 2019.
Article in English | WPRIM | ID: wpr-739461
ABSTRACT
Treatment of burning mouth syndrome (BMS) is challenging because there is no consensus regarding pharmalogical or nonpharmalogical therapies. The use of anticonvulsants is controversial. We present nine patients BMS who respond to pregabalin. They were diagnosed secondary BMS except two. Etiologic regulations were made firstly in patients with secondary BMS but symptoms did not decrease. We preferred pregabalin in all patients and got good results. Furthermore the addition of pregabalin to the treatment of two patients who did not respond adequately to duloxetine provided good results. We are only aware that pregabalin may reduce symptoms as a result of case reports. We believe that the diagnosis of pathologic etiology with appropriate diagnostic tests will result in better outcomes in treatment.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Social Control, Formal / Burning Mouth Syndrome / Burns / Consensus / Diagnosis / Diagnostic Tests, Routine / Pregabalin / Duloxetine Hydrochloride / Anticonvulsants Type of study: Diagnostic study / Practice guideline Limits: Humans Language: English Journal: Clinical Psychopharmacology and Neuroscience Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Social Control, Formal / Burning Mouth Syndrome / Burns / Consensus / Diagnosis / Diagnostic Tests, Routine / Pregabalin / Duloxetine Hydrochloride / Anticonvulsants Type of study: Diagnostic study / Practice guideline Limits: Humans Language: English Journal: Clinical Psychopharmacology and Neuroscience Year: 2019 Type: Article